Overview

DDR Genes Alteration and Response to Platinum-based Chemotherapy in Advanced Urothelial Cancer.

Status:
RECRUITING
Trial end date:
2027-01-07
Target enrollment:
Participant gender:
Summary
This study aims to prospectively observe whether certain alterations in some genes related to the DNA repair mechanism are related to better response to platinum-based chemotherapy used to treat metastatic bladder or urothelial cancers.
Phase:
PHASE4
Details
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Treatments:
Gemcitabine
Platinum